Story Poster
Photo by Rick Kimball/ISD
Notre Dame Football Recruiting

2021 DB Jordan Greer Enjoys Notre Dame Visit

March 24, 2019
2,487

2021 Parkway North (Mo.) defensive back Jordan Greer‍ made his way to Notre Dame on Saturday. The 6-foot-1, 145-pounder was able to experience practice and get a quick overview of the program, which left a lasting impression. 

“The day went well,” Greer told Irish Sports Daily. “I liked the campus. I’m glad I was able to see practice and learn more about the University.” 

Practice on Saturday morning was the highlight for Greer as he was able to see multiple aspects that impressed him. 

“It was very intense and exciting,” explained Greer. “I liked the way they run things during practice.

“I liked the way the coaches did things. I liked how they set up the drills and went through practice. It was similar to the way we do it at my school.” 

Notre Dame went live several times and it allowed the recruits in attendance to get a feel for the team, but also how competitive Brian Kelly’s program has become. 

“I loved to see them scrimmage,” stated Greer. “It showed how they can play and relates to what they can do in games.” 

Greer was also able to speak to a few members of the Notre Dame staff and they were able to explain why Notre Dame is an attractive program on and off the field. 

“I spoke to a few coaches,” Greer said. “They talked to me about coming to the school, graduating and being a true student-athlete.” 

The Missouri native was able to try on the uniform and see the campus, which made him feel at home. 

“The campus is very cultural,” Greer stated. “I can see myself going to Notre Dame and enjoying what they do here.” 

Greer has one visit lined up in the coming weeks, but he also knows he’d love to come back for a game in the fall. 

“I have a visit to Southern Illinois coming up,” said Greer. “I think that’s it for now. I would definitely back for another visit.” 

 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.